Investor Relations

News Releases

 
News Releases
  Date Title View
Nov 10, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that the Center for Medicare & Medicaid Services ("CMS") has assigned a unique Healthcare Common Procedure Coding System ("HCPCS") code, or J-Code, to its product MONOVISC®. The issuance of this code by CMS set...
Oct 29, 2014
Third-Quarter Total Revenue Grows 24% to $22.1 Million Earnings per Share Increase to $0.40 from $0.33 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid ...
Oct 16, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its third-quarter 2014 financial results after the close of the market on Wednesday, October 29, 2014. The company plans to hold a conference call the next day, Thursday, October 30 at 9:00 a....
Aug 4, 2014
Presentation to be Webcast Live at 10:30 a.m. ET BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will be presenting at the Canaccord Genuity 34th Annual Growth ...
Jul 30, 2014
Total Revenue Grows 26% to $26.3 Million Commercial Launch of Monovisc® Generates $5 Million Milestone Payment Earnings per Share Increase to $0.60 from $0.40 a Year Earlier BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nas...
Jul 30, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it has entered into a new agreement with Medline Industries, Inc. to commercialize the Company's advanced wound care product - Hyalomatrix®, in the United States on an exclusive basis through 2019...
Jul 15, 2014
BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its second-quarter 2014 financial results after the close of the market on Wednesday, July 30, 2014. The company plans to hold a conference call the next day, Thursday, July 31 at 9:00 a.m. ET...
Apr 29, 2014
Receives $17.5 Million in Monovisc® Milestone Payment Total Revenue Grows 123% to $34 Million Earnings per Share Increase to $0.97 from $0.21 a Year Earlier BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a...
Apr 16, 2014
BEDFORD, Mass--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its first-quarter 2014 financial results after the close of the market on Tuesday, April 29, 2014. The company plans to hold a conference call the next day, Wednesday, April 30 at 9:00 a.m. ET ...
Apr 15, 2014
Company's Commercial Partner, DePuy Synthes Mitek Sports Medicine, Records First Commercial Sale of Single-Injection Treatment for Osteoarthritis Knee Pain BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection,...

= add release to Briefcase